BioSpace News Archive

Biotech Bay

Akero Therapeutics to Present at Upcoming Healthcare Conferences in May

Akero Therapeutics, Inc. today announced that management will participate in the following investor conferences this month: BofA Securities 2022 Healthcare Conference: Fireside chat on Wednesday, May 11 at 8:40 a.m. PT. in Las Vegas, Nevada.

May 2, 2022
·
1 min read
Pharm Country

Physicians Foresee an Alzheimer’s Disease Treatment Revolution Supported by Advanced Testing Tools, New Quest Diagnostics Report Finds

Blood Test for Early Detection of Alzheimer’s Disease (AD) Risk Will Lead to Better Patient Care, Physicians Say; U.S. Adults Call for Earlier Evaluation and More Education.

May 2, 2022
·
9 min read
Biotech Beach

Arrowhead Pharmaceuticals to Participate in Upcoming May 2022 Conferences

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: TIDES USA 2022: Oligonucleotide and Peptide Therapeutics – May 9-12, 2022.

May 2, 2022
·
4 min read
Zucara Therapeutics Secures Additional Funding from GlycoNet and Mitacs for the Development of ZT-01

Zucara Therapeutics Inc. today announced that it has received second grants from each of GlycoNet and Mitacs to support the development of ZT-01 for the treatment of insulin-induced hypoglycemia in people with Type 2 diabetes (“T2D”).

May 2, 2022
·
3 min read
Business

DTx Pharma Announces Appointment of Kathie M. Bishop to its Board of Directors

DTx Pharma, Inc. today announced that it has appointed Kathie M. Bishop, PhD, to its Board of Directors.

May 2, 2022
·
2 min read
Business

Miravo Healthcare™ Announces First Quarter 2022 Results Release Date and Virtual Annual Meeting of Shareholders

Miravo Healthcare ™ Announces First Quarter 2022 Results Release Date and Virtual Annual Meeting of Shareholders.

May 2, 2022
·
4 min read
Business

Arrowhead Pharmaceuticals Appoints Victoria Vakiener to Board of Directors

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that the board of directors appointed veteran pharmaceutical industry executive Victoria Vakiener, as an independent director of the company, with a term beginning effective May 2, 2022.

May 2, 2022
·
3 min read
BioMidwest

Recursion to Participate in Upcoming Investor Conference - May 02, 2022

Recursion, the clinical-stage biotechnology company industrializing drug discovery by decoding biology, announced its participation in the following upcoming investor conference.

May 2, 2022
·
3 min read
Lone Star Bio

TFF Pharmaceuticals Announces Multiple Presentations Highlighting Broad Applicability of its Thin Film Freezing Technology at Respiratory Drug Delivery Meeting (RDD)

TFF Pharmaceuticals, Inc. today announced substantial new data to be presented on its technology platform at the Respiratory Drug Delivery (RDD) Meeting, which is taking place between May 1-5, 2022 in Orlando, Florida.

May 2, 2022
·
9 min read
Business

Gracell Biotechnologies to Report First Quarter 2022 Financial Results on Monday, May 16, 2022

Gracell Biotechnologies Inc. today announced that it plans to release unaudited financial results for the first quarter ended March 31, 2022 and provide an update on recent developments prior to the open of the U.S. financial markets on Monday, May 16, 2022.

May 2, 2022
·
1 min read